Pharmaceutical Analysis & Statistics in Europe Countries, September 2014

Talk to Louis

+1 718 618 4302

Publishers

You might be interested in: therapeutics, drug, cancer, more »

1-50 of about 13 000 reports

Purchase Reports From Reputable Market Research Publishers

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 ...

  • Industries : Therapy
  • Countries : Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark
MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible ...

  • Industries : Drug and Medication
  • Countries : World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • August 2014
  • by Global Data

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part ...

  • Industries : Pathology
  • Countries : Japan, China, World, United States, Spain, Italy, France, Germany
EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • July 2014
  • by Global Data

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023 Summary Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences ...

  • Industries : Pathology
  • Countries : Germany, World, United States, Spain, United Kingdom, Italy, France, Japan
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World
EU5 Hernia Repair Market Outlook to 2020

EU5 Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • July 2014
  • by Global Data

EU5 Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "EU5 Hernia Repair Market Outlook to 2020", provides key market data on the EU5 Hernia Repair market. The report provides value, ...

  • Industries : Pathology
  • Countries : United Kingdom, Spain, Italy, France, Germany, Europe
United Kingdom Hernia Repair Market Outlook to 2020

United Kingdom Hernia Repair Market Outlook to 2020

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

United Kingdom Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "United Kingdom Hernia Repair Market Outlook to 2020", provides key market data on the United Kingdom Hernia Repai ...

  • Industries : Pathology
  • Countries : United Kingdom
France Hernia Repair Market Outlook to 2020

France Hernia Repair Market Outlook to 2020

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

France Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "France Hernia Repair Market Outlook to 2020", provides key market data on the France Hernia Repair market. The report provides ...

  • Industries : Pathology
  • Countries : France
Germany Hernia Repair Market Outlook to 2020

Germany Hernia Repair Market Outlook to 2020

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Germany Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Germany Hernia Repair Market Outlook to 2020", provides key market data on the Germany Hernia Repair market. The report provides ...

  • Industries : Pathology
  • Countries : Germany
Italy Hernia Repair Market Outlook to 2020

Italy Hernia Repair Market Outlook to 2020

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Italy Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Italy Hernia Repair Market Outlook to 2020", provides key market data on the Italy Hernia Repair market. The report provides ...

  • Industries : Pathology
  • Countries : Italy
Spain Hernia Repair Market Outlook to 2020

Spain Hernia Repair Market Outlook to 2020

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Spain Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Spain Hernia Repair Market Outlook to 2020", provides key market data on the Spain Hernia Repair market. The report provides ...

  • Industries : Pathology
  • Countries : Spain
Russia Hernia Repair Market Outlook to 2020

Russia Hernia Repair Market Outlook to 2020

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Russia Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Russia Hernia Repair Market Outlook to 2020", provides key market data on the Russia Hernia Repair market. The report provides ...

  • Industries : Pathology
  • Countries : Russian Federation
Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

  • $ 2 488
  • Industry report
  • July 2014
  • by MarketSizeInfo

This is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vitamins and provitamins. The publication provides the market size, growth ...

  • Industries : Vitamin and Supplement
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, North America, Peru, Oman
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014', provides an overview of the Vaginal ...

  • Industries : Pathology
  • Countries : World, Sweden
Liver Failure - Pipeline Review, H2 2014

Liver Failure - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

Liver Failure - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Liver Failure - Pipeline Review, H2 2014', provides an overview of the Liver Failure's therapeutic pipeline. This report provides ...

  • Industries : Drug Discovery and Development
  • Countries : World, Spain
Women Infertility - Pipeline Review, H2 2014

Women Infertility - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

Women Infertility - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Women Infertility - Pipeline Review, H2 2014', provides an overview of the Women Infertility's therapeutic pipeline. This ...

  • Industries : Drug and Medication
  • Countries : World, Switzerland
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014', provides an overview of the ...

  • Industries : Pathology
  • Countries : Belgium
Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014

Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014', provides an overview of the Genital ...

  • Industries : Pathology
  • Countries : World, Czech Republic, Taiwan
Intermittent Claudication - Pipeline Review, H1 2014

Intermittent Claudication - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Intermittent Claudication - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Intermittent Claudication - Pipeline Review, H1 2014', provides an overview of the Intermittent Claudication's therapeutic ...

  • Industries : Drug Discovery and Development
  • Countries : South Korea, World, Germany, Israel
Pompe Disease - Pipeline Review, H1 2014

Pompe Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Pompe Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Pompe Disease - Pipeline Review, H1 2014', provides an overview of the Pompe Disease's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : Belgium, World
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Latvia's disease profile and relatively low per-capita consumption of pharmaceuticals (compared with the rest of developed Europe) is a clear illustration of the need for innovative medicines. ...

  • Industries : Drug and Medication
  • Countries : Latvia
Croatia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Croatia’s pharmaceutical industry appears relatively stable, recording 0.1% growth in 2010 – a year in which economic challenges were sizeable. Compared with its south eastern European neighbours, ...

  • Industries : Pharmaceutical
  • Countries : Croatia
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: A year has passed since the EU/IMF/ECB’s rescue package was approved, and the obligations that form part of the economic adjustment programme have had, and ...

  • Industries : Generic Drug
  • Countries : Portugal
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: In response to the expected passage of key drug policy reforms in the Czech Republic, BMI has cut its projections for pharmaceutical industry growth in 2012 to 0.0%, with the prospects of lowe ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Despite a more positive economic outlook, Lithuania is still considered one of the less attractive pharmaceutical industry s within Central and Eastern Europe (CEE). Factors such as difficult ...

  • Industries : Pharmaceutical
  • Countries : Lithuania
Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Our view that Greece's pharmaceutical industry is set for a decade of decline remains firmly in play. The list of challenges is sizeable: the combination of price erosion mechanisms; rapid generic ...

  • Industries : Drug and Medication
  • Countries : Greece
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The short-term outlook for the Serbian pharmaceutical industry will continue to be clouded by corruption, debts accrued by the country’s health insurance ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Slovakia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Slovakia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Despite the formation of new government in Slovakia, our contractionary outlook for the pharmaceutical industry has been maintained as key drug policy reforms ...

  • Industries : Prescription Drug
  • Countries : Slovakia (slovak Republic)
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Full-year trade data for 2011 and Q112 has confirmed that Moldova’s pharmaceutical industry has returned to more normal growth. However, with regional economic ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
About 9 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe - Forecast

  • An Assessment of the Health and Social Care Needs of Older Peopl...
  • August 2014
    129 pages
  • Coronary Heart ...  

    Mental Illness  

    Cardiovascular ...  

  • United Kingdom  

    Europe  

View report >

46 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.